Acute lymphoblastic leukemia

Can Immunotherapy be Democratized?
News & Features

Can Immunotherapy be Democratized?

Kathy Vuksanaj -
0
Charging to the Frontline
News & Features

Charging to the Frontline

Chris Anderson -
0
Autolus Confirms Positive Phase II Findings for Obe-cel CAR T-Cell Therapy
News & Features

Autolus Confirms Positive Phase II Findings for Obe-cel CAR T-Cell Therapy

Helen Albert -
0
Immunotherapy Substantially Improves Outcomes for Babies with Leukemia
News & Features

Immunotherapy Substantially Improves Outcomes for Babies with Leukemia

Chris Anderson -
0
Children with Leukemia Living on Texas-Mexico Border More Likely to Die than Those Elsewhere in the State
News & Features

Children with Leukemia Living on Texas-Mexico Border More Likely to Die than Those Elsewhere in the State

Chris Anderson -
0
Broadening the Scope of Clinical Trials: The Changing Role of Real-World Evidence
Informatics

Broadening the Scope of Clinical Trials: The Changing Role of Real-World Evidence

Helen Albert -
0
Drug Response Study of Leukemia Subtypes Advances Precise Patient-Therapy Matching
Molecular Dx

Drug Response Study of Leukemia Subtypes Advances Precise Patient-Therapy Matching

Chris Anderson -
0
Extended Maintenance Therapy Improves Outcomes in Childhood ALL
News & Features

Extended Maintenance Therapy Improves Outcomes in Childhood ALL

Chris Anderson -
0
Immunotherapy Plus Consolidation Chemo Improves Survival in B Lineage ALL
News & Features

Immunotherapy Plus Consolidation Chemo Improves Survival in B Lineage ALL

Chris Anderson -
0
CAR T-Cell Therapy Performs Just as Well in Low-Income Kids as in Wealthier Kids
News & Features

CAR T-Cell Therapy Performs Just as Well in Low-Income Kids as in Wealthier Kids

Malorye Branca -
0
123Page 1 of 3

Related Content

Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine